Examine This Report on カソデックス（ビカルタミド）
A direct compound recognized in a display for inhibitors of protein kinase C was optimized to offer a methyl-piperazine by-product that was originally named STI571 (imatinib, here now called Glivec or Gleevec), which was chosen as quite possibly the most promising prospect for clinical improvement. 皮膚症状は重症化することもありま�